Preblick Ryan 4
4 · Indivior Pharmaceuticals, Inc. · Filed Feb 12, 2026
Research Summary
AI-generated summary of this filing
Indivior (INDV) CFO Ryan Preblick Receives RSU Awards
What Happened
Ryan Preblick, Chief Financial Officer of Indivior Pharmaceuticals (INDV), was granted a total of 150,868 restricted stock units (RSUs) in two awards reported Feb 9–10, 2026. One award for 37,358 RSUs was granted Feb 10, 2026 (nominal $0 price). A second, derivative award for 113,510 RSUs was certified as earned on Feb 9, 2026 (nominal $0 price) following satisfaction of prior performance conditions. No cash was paid for these awards — they are compensation grants, not open-market purchases.
Key Details
- Transaction dates: 2026-02-09 (113,510 RSUs, derivative/performance-certified) and 2026-02-10 (37,358 RSUs). Report filed 2026-02-12 (timely).
- Price: $0.00 per RSU (awarded, not purchased). Total awarded: 150,868 RSUs.
- Vesting: 37,358 RSUs vest in three equal annual installments beginning Feb 10, 2027 (subject to continued service). The 113,510 RSU award was a conditional 2023 performance award; performance was certified Feb 9, 2026 and it vests (subject to continued employment) on Mar 3, 2026, after which vested shares are subject to a two‑year holding period before release.
- Shares owned after transaction: not specified in the filing.
- Transaction code: A = Award/Grant. The 113,510 entry is reported as a derivative award (performance-based).
- Filing timeliness: Reported within required Form 4 timeframe (not marked late).
- Exhibit: Power of Attorney filed as Exhibit 24.
Context: These entries are equity compensation grants, common for executives as part of pay and retention programs. They do not involve an open-market purchase or sale and are contingent on continued employment (and, for the larger award, prior performance certification and a subsequent holding period). Such grants signal company compensation events but are not direct buys or sells that reveal immediate trading intent.
Insider Transaction Report
- Award
Common Stock
[F1]2026-02-10+37,358→ 317,940 total - Award
Performance Stock Units
[F2]2026-02-09+113,510→ 113,510 totalExercise: $0.00From: 2028-03-03→ Common Stock (113,510 underlying)
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock, vesting in three equal annual installments beginning on February 10, 2027, the first anniversary of the grant, subject to the Reporting Person's continued service with the Issuer.
- [F2]On March 3, 2023, the Reporting Person was granted a conditional award for 113,510 shares, subject to satisfaction of performance conditions, which were certified on February 9, 2026. The award vests, subject to continued employment conditions, on March 3, 2026. The shares will then be subject to an additional two-year Holding Period before the vested Shares are released to the Reporting Person.